MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath TumorMiguel A. Miranda-Román, Ping Chi|Clinical Cancer Research|2024Cited by 7